Merit Medical Systems, Inc (NASDAQ: MMSI) on Friday, plunged -7.30% from the previous trading day, before settling in for the closing price of $93.18. Within the past 52 weeks, MMSI’s price has moved between $78.12 and $111.45.
Annual sales at Healthcare sector company grew by 83.71% over the past five years. The company achieved an average annual earnings per share of 7.93%. With a float of $57.85 million, this company’s outstanding shares have now reached $59.29 million.
Merit Medical Systems, Inc (MMSI) Insider Updates
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Merit Medical Systems, Inc is 2.43%, while institutional ownership is 104.37%. The most recent insider transaction that took place on Jan 06 ’26, was worth 450,000. In this transaction CHIEF OPERATING OFFICER of this company sold 5,000 shares at a rate of $90.00, taking the stock ownership to the 28,369 shares. Before that another transaction happened on Jan 06 ’26, when Company’s Officer proposed sale 5,000 for $90.00, making the entire transaction worth $450,000.
Merit Medical Systems, Inc (MMSI) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.93 earnings per share (EPS) for the period topping the consensus outlook (set at 0.83) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.89 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.17% during the next five years compared to 83.71% growth over the previous five years of trading.
Merit Medical Systems, Inc (NASDAQ: MMSI) Trading Performance Indicators
Merit Medical Systems, Inc (MMSI) is currently performing well based on its current performance indicators. A quick ratio of 2.86 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.75. Likewise, its price to free cash flow for the trailing twelve months is 26.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.95, a number that is poised to hit 0.95 in the next quarter and is forecasted to reach 4.01 in one year’s time.
